Virbac Offers Exciting Complimentary Livestream Event for Mast Cell Tumour MCT May’
VetClick,
Home > News 2 hours ago 39 views Posted 11th April, 2022 14h01 Author Virbac Animal Health Following the launch of STELFONTA®…
Home > News 2 hours ago 39 views Posted 11th April, 2022 14h01 Author Virbac Animal Health Following the launch of STELFONTA®…
Home > News 27 seconds ago 0 views Posted 10th January, 2022 14h00 Author Virbac Animal Health The busy Virbac ‘STELFONTA®…
16-Dec-2021 Intellasia | PR Newswire Asia | 2:58 AM QBiotics commences the Australian commercial launch of its lead veterinary…
QBiotics commences the Australian commercial launch of its lead veterinary drug, STELFONTA®, which is approved by the…
BRISBANE, Australia, Dec. 16, 2021 /PRNewswire/ -- QBiotics Group Limited (QBiotics), a life sciences company developing novel…
QBiotics commences the Australian commercial launch of its lead veterinary drug, STELFONTA®, which is approved by the…
STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary…
STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary…
BRISBANE, Australia, Nov. 18, 2020 /PRNewswire/ -- QBiotics Group Limited (QBiotics), a life sciences company developing novel…
QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours PR Newswire BRISBANE, Australia, Nov.
STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary…
STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary…
STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary…
STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary…
STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary…
STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary…
STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary…
17-Nov-2020 Intellasia | PR Newswire Asia | 10:51 AM STELFONTA (tigilanol tiglate injection) is now approved by the U.S.
STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary…
/PRNewswire/ -- Australian life sciences company, QBiotics Group Limited (QBiotics) has commercialised the first product for…
/PRNewswire/ -- Australian life sciences company, QBiotics Group Limited (QBiotics) has commercialised the first product for…
BRISBANE, Australia, April 28, 2020 /PRNewswire/ -- Australian life sciences company, QBiotics Group Limited (QBiotics) has…
STELFONTA (tigilanol tiglate) is now available as the first pharmaceutical treatment for all grades of canine non-metastatic…
/PRNewswire/ -- Australian life sciences company, QBiotics Group Limited (QBiotics) has commercialised the first product for…
/PRNewswire/ -- Mit der Einführung von STELFONTA® auf dem europäischen Markt hat das australische Life-Science-Unternehmen…
BRISBANE Le STELFONTA® (tiglate de tigilanol), disponible dès aujourd'hui, est le premier traitement pharmaceutique existant…
/PRNewswire/ -- Australian life sciences company, QBiotics Group Limited (QBiotics) has commercialised the first product for…
BRISBANE, Australia, April 28, 2020 /PRNewswire/ -- Australian life sciences company, QBiotics Group Limited (QBiotics) has…
BRISBANE, Australie, 28 avril 2020 /PRNewswire/ -- QBiotics Group Limited (QBiotics), société australienne de sciences de la vie…
/PRNewswire/ -- Australian life sciences company, QBiotics Group Limited (QBiotics) has commercialised the first product for…
/PRNewswire/ -- Australian life sciences company, QBiotics Group Limited (QBiotics) has commercialised the first product for…
QBiotics commercialises first tigilanol tiglate pharmaceutical product with launch of STELFONTA® PR Newswire BRISBANE, Australia…
/PRNewswire/ -- Australian life sciences company, QBiotics Group Limited (QBiotics) has commercialised the first product for…
/ / -- Australian life sciences company, QBiotics Group Limited (QBiotics) has commercialised the first product for its lead…
BRISBANE, Australia, April 28, 2020 /PRNewswire/ -- Australian life sciences company, QBiotics Group Limited (QBiotics) has…
BRISBANE STELFONTA (tiglate de tigilanol) est indiqué dans le traitement de tumeurs mastocytaires sous-cutanées non résécables…
STELFONTA® (tiglate de tigilanol) décroche l'autorisation de l'EMA (l'Agence européenne du médicament), ce qui en fait le…
Die Europäische Arzneimittelagentur EMA erteilt die Zulassung für Tigilanol Tiglat (STELFONTA®), das erste Pharmazeutikum auf…
STELFONTA® (tigilanol-tiglaat) is goedgekeurd door het Europees Geneesmiddelenbureau (EMA), waarmee het de eerste…
STELFONTA® (tiglate de tigilanol) décroche l'autorisation de l'EMA (l'Agence européenne du médicament), ce qui en fait le…
STELFONTA® (tiglate de tigilanol) décroche l'autorisation de l'EMA (l'Agence européenne du médicament), ce qui en fait le…
Die Europäische Arzneimittelagentur EMA erteilt die Zulassung für Tigilanol Tiglat (STELFONTA®), das erste Pharmazeutikum auf…
STELFONTA (tigilanol tiglate) approved by the European Medicines Agency (EMA), making it the first pharmaceutical treatment…
STELFONTA® (tigilanol tiglate) approved by the European Medicines Agency (EMA), making it the first pharmaceutical treatment…
STELFONTA® (tigilanol tiglate) approved by the European Medicines Agency (EMA), making it the first pharmaceutical treatment…
STELFONTA® (tigilanol tiglate) approved by the European Medicines Agency (EMA), making it the first pharmaceutical treatment…